1. Ranjbary AG, Mehrzad J, Dehghani H, Abdollahi A, Hosseinkhani S. (2020). Variation in Blood and Colorectal Epithelia's Key Trace Elements along with Expression of Mismatch Repair Proteins from Localized and Metastatic Colorectal Cancer Patients. Biol Trace Elem Res. 194(2):629.
2. Mauri G, Sartore-Bianchi A, Russo AG, Marsoni S, Bardelli A, Siena S. (2019). Early-onset colorectal cancer in young individuals. Mol Oncol. 13(2):109-131.
3. Siegel RL, Jakubowski CD, Fedewa SA, Davis A, Azad NS. (2020). Colorectal Cancer in the Young: Epidemiology, Prevention, Management. Am Soc Clin Oncol Educ Book. 40:1-14.
4. Arruebo M, Vilaboa N, Sáez-Gutierrez B, Lambea J, Tres A, Valladares M, González-Fernández A. (2011). Assessment of the evolution of cancer treatment therapies. Cancers (Basel). 3(3):3279-330.
5. Hassanzadeh P, Fullwood I, Sothi S, Aldulaimi D. (2011). Cancer nanotechnology. Gastroenterol Hepatol Bed Bench. 4(2):63-9.
6. Boateng F, Ngwa W. (2019). Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications. Int J Mol Sci. 21(1):273.
7. Zhao CY, Cheng R, Yang Z, Tian ZM. (2018). Nanotechnology for Cancer Therapy Based on Chemotherapy. Molecules. 23(4):826.
8. Ali A, Zafar H, Zia M, Ul Haq I, Phull AR, Ali JS, Hussain A. (2016). Synthesis, characterization, applications, and challenges of iron oxide nanoparticles. Nanotechnol Sci Appl. 9:49-67.
9. Ganapathe LS, Mohamed MA, Mohamad Yunus R, Berhanuddin DD. (2020). Magnetite (Fe3O4) Nanoparticles in Biomedical Application: From Synthesis to Surface Functionalisation. Magnetochemistry. 6(4):68.
10. Namvar F, Rahman HS, Mohamad R, Baharara J, Mahdavi M, Amini E, Chartrand MS, Yeap SK. (2014). Cytotoxic effect of magnetic iron oxide nanoparticles synthesized via seaweed aqueous extract. Int J Nanomedicine. 9:2479-88.
11. Kanagesan S, Hashim M, Tamilselvan S, Alitheen NB, Ismail I, Hajalilou A, Ahsanul K. (2013). Synthesis, characterization, and cytotoxicity of iron oxide nanoparticles. Advances in Materials Science and Engineering. 2013.
12. Wu M, Huang S. (2017). Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment. Mol Clin Oncol. 7(5):738-746.
13. Manke A, Wang L, Rojanasakul Y. (2013). Mechanisms of nanoparticle-induced oxidative stress and toxicity. BioMed research international. 2013.
14. Yu Z, Li Q, Wang J, Yu Y, Wang Y, Zhou Q, Li P. (2020). Reactive Oxygen Species-Related Nanoparticle Toxicity in the Biomedical Field. Nanoscale Res Lett. 15(1):115.
15. Erofeev A, Gorelkin P, Garanina A, Alova A, Efremova M, Vorobyeva N, Edwards C, Korchev Y, Majouga A. (2018). Novel method for rapid toxicity screening of magnetic nanoparticles. Scientific reports. 8(1):1-1.
16. Huang YW, Cambre M, Lee HJ. (2017). The Toxicity of Nanoparticles Depends on Multiple Molecular and Physicochemical Mechanisms. Int J Mol Sci. 18(12):2702.
17. Lujan H, Sayes CM. (2017). Cytotoxicological pathways induced after nanoparticle exposure: studies of oxidative stress at the 'nano-bio' interface. Toxicol Res (Camb). 6(5):580-594.
18. Fu PP, Xia Q, Hwang HM, Ray PC, Yu H. (2014). Mechanisms of nanotoxicity: generation of reactive oxygen species. Journal of food and drug analysis. 22(1):64-75.
19. Yu Z, Li Q, Wang J, Yu Y, Wang Y, Zhou Q, Li P. (2020). Reactive oxygen species-related nanoparticle toxicity in the biomedical field. Nanoscale research letters. 15:1-4.
20. Rashid H, Mansoor MA, Haider B, Nasir R, Abd Hamid SB, Abdulrahman A. (2020). Synthesis and characterization of magnetite nano particles with high selectivity using in-situ precipitation method. Separation Science and Technology. 55(6):1207-15.
21. Lodhia J, Mandarano G, Ferris NJ, Eu P, Cowell SF. (2010). Development and use of iron oxide nanoparticles (Part 1): Synthesis of iron oxide nanoparticles for MRI. Biomedical imaging and intervention journal. 6(2):e12.
22. Hebling J, Bianchi L, Basso FG, Scheffel DL, Soares DG, Carrilho MR, Pashley DH, Tjäderhane L, de Souza Costa CA. (2015). Cytotoxicity of dimethyl sulfoxide (DMSO) in direct contact with odontoblast-like cells. Dent Mater. 31(4):399-405.
23. Zhang L, Chen H, Wang M, Song X, Ding F, Zhu J, Li X. (2018). Effects of glabridin combined with 5-fluorouracil on the proliferation and apoptosis of gastric cancer cells. Oncology letters. 15(5):7037-45.
24. Kojima K, Takahashi S, Saito S, Endo Y, Nittami T, Nozaki T, Sobti RC, Watanabe M. (2018). Combined effects of Fe3O4 nanoparticles and chemotherapeutic agents on prostate cancer cells in vitro. Applied Sciences. 8(1):134.
25. Manke A, Wang L, Rojanasakul Y. (2013). Mechanisms of nanoparticle-induced oxidative stress and toxicity. Biomed Res Int. 942916.
26. Jawaid P, Rehman MU, Zhao QL, Misawa M, Ishikawa K, Hori M, Shimizu T, Saitoh JI, Noguchi K, Kondo T. (2020). Small size gold nanoparticles enhance apoptosis-induced by cold atmospheric plasma via depletion of intracellular GSH and modification of oxidative stress. Cell death discovery. 6(1):1-2.
27. Sato A, Itcho N, Ishiguro H, Okamoto D, Kobayashi N, Kawai K, Kasai H, Kurioka D, Uemura H, Kubota Y, Watanabe M. (2013). Magnetic nanoparticles of Fe3O4 enhance docetaxel-induced prostate cancer cell death. Int. J. Nanomedicine. 8:3151.
28. Shen S, Liu Y, Huang P, Wang J. (2009). In vitro cellular uptake and effects of Fe3O4 magnetic nanoparticles on HeLa cells. J Nanosci Nanotechnol. 9(5):2866-71.
29. Mustafa T, Watanabe F, Monroe W, Mahmood M, Xu Y, Saeed LM, Karmakar A, Casciano D, All S, Biris AS. (2011). Impact of gold nanoparticle concentration on their cellular uptake by MC3T3-E1 mouse osteoblastic cells as analyzed by transmission electron microscopy. J. Nanomed. Nanotechnol. 2(6):1000118.
30. Chauhan A, Kumar R, Singh P, Jha SK, Kuanr BK. (2020). RF hyperthermia by encapsulated Fe3O4 nanoparticles induces cancer cell death via time-dependent caspase-3 activation. Nanomedicine. 15(04):355-79.
31. Ozaki T, Nakagawara A. (2011). Role of p53 in Cell Death and Human Cancers. Cancers (Basel). 3(1):994-1013.
32. Elmore S. (2007). Apoptosis: a review of programmed cell death. Toxicol Pathol. 35(4):495-516.
33. Ivanova D, Zhelev Z, Aoki I, Bakalova R, Higashi T. (2016). Overproduction of reactive oxygen species - obligatory or not for induction of apoptosis by anticancer drugs. Chin J Cancer Res. 28(4):383-96.
34. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. (2007). Mitochondria, oxidative stress and cell death. Apoptosis. 12(5):913-22.
35. Kasai S, Shimizu S, Tatara Y, Mimura J, Itoh K. (2020). Regulation of Nrf2 by mitochondrial reactive oxygen species in physiology and pathology. Biomolecules. 10(2):320.
36. Dielschneider RF, Henson ES, Gibson SB. (2017). Lysosomes as Oxidative Targets for Cancer Therapy. Oxid Med Cell Longev. 3749157.
37. Redza-Dutordoir M, Averill-Bates DA. (2016). Activation of apoptosis signalling pathways by reactive oxygen species. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 1863(12):2977-92.
38. Giorgi C, Baldassari F, Bononi A, Bonora M, De Marchi E, Marchi S, Missiroli S, Patergnani S, Rimessi A, Suski JM, Wieckowski MR, Pinton P. (2012). Mitochondrial Ca(2+) and apoptosis. Cell Calcium. 52(1):36-43.
39. Feno S, Butera G, Vecellio Reane D, Rizzuto R, Raffaello A. (2019). Crosstalk between calcium and ROS in pathophysiological conditions. Oxid. Med. Cell. Longev. 24;2019.
40. Zhu L, Han MB, Gao Y, Wang H, Dai L, Wen Y, Na LX. (2015). Curcumin triggers apoptosis via upregulation of Bax/Bcl-2 ratio and caspase activation in SW872 human adipocytes. Mol Med Rep. 12(1):1151-6.
41. Alarifi S, Ali H, Saad Alkahtani MS. (2017). Regulation of apoptosis through bcl-2/bax proteins expression and DNA damage by nano-sized gadolinium oxide. Int. J. Nanomedicine. 12:4541.
42. Yue J, López JM. (2020). Understanding MAPK signaling pathways in apoptosis. Int. J. Mol. Sci. 21(7):2346.